3SBio Inc., a leading biopharmaceutical company headquartered in China, has established itself as a key player in the biotechnology industry since its founding in 1993. With a strong operational presence across major regions in Asia, 3SBio focuses on the development, manufacturing, and marketing of innovative therapies, particularly in the fields of oncology, nephrology, and autoimmune diseases.
The company is renowned for its core products, including recombinant human erythropoietin and other biologics, which are distinguished by their high quality and efficacy. Over the years, 3SBio has achieved significant milestones, including successful product launches and strategic partnerships, solidifying its market position as a trusted provider of biopharmaceutical solutions. With a commitment to advancing healthcare, 3SBio continues to drive innovation and improve patient outcomes in the biopharmaceutical landscape.
-18 vs industry average
3sbio’s score of 20 is lower than 35% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at 3sbio?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Pharmaceutical Preparation Manufacturing has below-average carbon intensity
Industry performance
The Pharmaceutical Preparation Manufacturing industry has reduced its overall emissions by 19% since 0
Emissions trajectory 2020 – 2027
Reported emissions
Scope 3 accounts for ••• of total emissions.
3sbio's reported carbon emissions
In 2024, 3SBio reported total emissions of approximately 69.1 million kg CO2e, comprising 13,304,070 kg CO2e from Scope 1 and 55,832,050 kg CO2e from Scope 2 emissions. The company has consistently disclosed its emissions data, with previous years showing a total of approximately 60.6 million kg CO2e in 2023 and about 45.9 million kg CO2e in 2022. 3SBio has not set specific reduction targets or initiatives as part of its climate commitments, and there are no emissions data available for Scope 3. The company’s emissions data is not cascaded from any parent organisation, indicating that it operates independently in its reporting. Overall, 3SBio's emissions profile reflects a commitment to transparency, although further steps towards formal reduction targets could enhance its climate strategy.
Unlock detailed emission data
Access structured emission data, company specific factors and auditable source documents
3sbio’s Climate Goals (2030 & 2050)
No climate goals have been disclosed for 3sbio yet.
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Emissions comparison with industry peers
View similar organisations
3sbio
Usage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn moreCurious to see your top suppliers emissions?
Book a demo for a pilot project